COSCIENS Biopharma Inc. Interest Expense Income Net Defined Benefit Liability Asset
COSCIENS Biopharma Inc. (CSCIF) reported Interest Expense Income Net Defined Benefit Liability Asset of $825.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-25.
Financial Statements › Expense Statement › Interest Expense
ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset · last filed 2026-03-25
- COSCIENS Biopharma Inc. interest expense income net defined benefit liability asset for the quarter ending 2025-12-31 was $211.00K, a 6.03% increase year-over-year.
- COSCIENS Biopharma Inc. interest expense income net defined benefit liability asset for the quarter ending 2025-09-30 was $210.00K, a 1.94% increase year-over-year.
- COSCIENS Biopharma Inc. interest expense income net defined benefit liability asset for the quarter ending 2025-06-30 was $212.00K.
- COSCIENS Biopharma Inc. interest expense income net defined benefit liability asset for the quarter ending 2025-03-31 was $192.00K, a 3.78% increase year-over-year.
| Period end | Interest Expense Income Net Defined Benefit Liability Asset 3 month | Interest Expense Income Net Defined Benefit Liability Asset 6 month | Interest Expense Income Net Defined Benefit Liability Asset 9 month | Interest Expense Income Net Defined Benefit Liability Asset 12 month |
|---|---|---|---|---|
| 2025-12-31 | $211.00K derived: 20-F 12 month − 6-K 9 month · filed 2026-03-25 | $421.00K derived: sum of 2 quarters · filed 2026-03-25 | $633.00K derived: sum of 3 quarters · filed 2026-03-25 | $825.00K 20-F · filed 2026-03-25 |
| 2025-09-30 | $210.00K derived: 6-K 9 month − 6-K 6 month · filed 2025-11-12 | $422.00K derived: sum of 2 quarters · filed 2025-11-12 | $614.00K 6-K · filed 2025-11-12 | $813.00K derived: sum of 4 quarters · filed 2026-03-25 |
| 2025-06-30 | $212.00K derived: 6-K 6 month − 6-K 3 month · filed 2025-08-14 | $404.00K 6-K · filed 2025-08-14 | $603.00K derived: sum of 3 quarters · filed 2026-03-25 | $809.00K derived: sum of 4 quarters · filed 2026-03-25 |
| 2025-03-31 | $192.00K 6-K · filed 2025-05-13 | $391.00K derived: sum of 2 quarters · filed 2026-03-25 | $597.00K derived: sum of 3 quarters · filed 2026-03-25 | $478.00K derived: sum of 4 quarters · filed 2026-03-25 |
| 2024-12-31 | $199.00K derived: 20-F 12 month − 6-K 9 month · filed 2026-03-25 | $405.00K derived: sum of 2 quarters · filed 2026-03-25 | $286.00K derived: sum of 3 quarters · filed 2026-03-25 | $471.00K 20-F · filed 2026-03-25 |
| 2024-09-30 | $206.00K derived: 6-K 9 month − 6-K 6 month · filed 2024-11-12 | $87.00K derived: sum of 2 quarters · filed 2024-11-12 | $272.00K 6-K · filed 2024-11-12 | $479.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2024-06-30 | -$119.00K derived: 6-K 6 month − 6-K 3 month · filed 2024-08-13 | $66.00K 6-K · filed 2024-08-13 | $273.00K derived: sum of 3 quarters · filed 2024-08-13 | $471.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2024-03-31 | $185.00K 6-K · filed 2024-05-16 | $392.00K derived: sum of 2 quarters · filed 2024-07-17 | $590.00K derived: sum of 3 quarters · filed 2024-07-17 | $791.00K derived: sum of 4 quarters · filed 2024-07-17 |
| 2023-12-31 | $207.00K derived: 20-F/A 12 month − 6-K 9 month · filed 2024-07-17 | $405.00K derived: sum of 2 quarters · filed 2024-07-17 | $606.00K derived: sum of 3 quarters · filed 2024-07-17 | $807.00K 20-F/A · filed 2024-07-17 |
| 2023-09-30 | $198.00K derived: 6-K 9 month − 6-K 6 month · filed 2023-11-09 | $399.00K derived: sum of 2 quarters · filed 2023-11-09 | $600.00K 6-K · filed 2023-11-09 | $685.00K derived: sum of 4 quarters · filed 2024-07-17 |
| 2023-06-30 | $201.00K derived: 6-K 6 month − 6-K 3 month · filed 2023-08-09 | $402.00K 6-K · filed 2023-08-09 | $487.00K derived: sum of 3 quarters · filed 2024-07-17 | $548.00K derived: sum of 4 quarters · filed 2024-07-17 |
| 2023-03-31 | $201.00K 6-K · filed 2023-05-09 | $286.00K derived: sum of 2 quarters · filed 2024-07-17 | $347.00K derived: sum of 3 quarters · filed 2024-07-17 | $416.00K derived: sum of 4 quarters · filed 2024-07-17 |
| 2022-12-31 | $85.00K derived: 20-F/A 12 month − 6-K 9 month · filed 2024-07-17 | $146.00K derived: sum of 2 quarters · filed 2024-07-17 | $215.00K derived: sum of 3 quarters · filed 2024-07-17 | $295.00K 20-F/A · filed 2024-07-17 |
| 2022-09-30 | $61.00K derived: 6-K 9 month − 6-K/A 6 month · filed 2022-11-03 | $130.00K derived: sum of 2 quarters · filed 2022-11-03 | $210.00K 6-K · filed 2022-11-03 | |
| 2022-06-30 | $69.00K derived: 6-K/A 6 month − 6-K 3 month · filed 2022-08-04 | $149.00K 6-K/A · filed 2022-08-04 | ||
| 2022-03-31 | $80.00K 6-K · filed 2022-05-11 | |||
| 2021-12-31 | $88.00K 20-F/A · filed 2024-02-15 | |||
| 2019-09-30 | $49.00K derived: 6-K 9 month − 6-K 6 month · filed 2019-11-07 | $161.00K 6-K · filed 2019-11-07 | ||
| 2019-06-30 | $112.00K 6-K · filed 2019-08-13 | |||
| 2018-12-31 | $225.00K 6-K · filed 2019-11-07 |